Fig. 6: Cross-evaluation of high seroprevalence community samples with spike antigens from other coronaviruses. | Nature Communications

Fig. 6: Cross-evaluation of high seroprevalence community samples with spike antigens from other coronaviruses.

From: Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

Fig. 6

a IgG absorbance of spike antigens from SARS-CoV-2, previous epidemic (MERS and SARS1), and seasonal (OC43 and HKU1) coronaviruses in archival pre-2019 samples (left) and high-incidence community (right). Color scale: yellow = high OD (4), purple = low OD (<0.5). b Scatter plots (with linear models and R-squared values) between IgG signal from SARS-CoV-2 spike and other coronavirus spike proteins. c Signal intensity for recombinant antibody control (rAB1 = spike monoclonal; rAB2 = RBD monoclonal), known SARS-CoV-2 nasal swab positive patient control (PCR+), and pre-2019 archival control (ARCH) samples for OC43, HKU1, MERS, and SARS1. Source data are provided as a Source Data file.

Back to article page